Navigation Links
New Drug Promising Against Tough-to-Treat Kidney Cancer
Date:10/30/2007

Axitinib produced good responses in almost half of patients, study found

TUESDAY, Oct. 30 (HealthDay News) -- An experimental drug called axitinib shows promise for treating people with what's known as cytokine-refractory metastatic kidney cancer -- a group of patients who typically have a poor response to drug treatment.

Axitinib is a selective inhibitor of cancer-linked proteins known as vascular endothelial growth factor receptors 1, 2 and 3.

As reported in the November issue of The Lancet Oncology, the phase II study of 52 patients treated with the drug found that 23 patients had complete or partial responses (some of which were long lasting), and 12 of these patients progressed during the study, with a duration of response ranging from four months to 26 months.

The French researchers also found that 22 patients showed stable disease for longer than eight weeks, including 13 patients with stable disease for 24 weeks or longer.

Four patients had early disease progression, and 30 patients had high blood pressure related to the treatment. In general, side effects were manageable and controlled by dose modification or supportive care, the researchers said.

"The objective response and time to progression in our study suggest that axitinib might be a promising drug in the treatment of patients with metastatic renal-cell cancer, although a randomized controlled trial is needed to confirm this finding," study author Olivier Rixe, a professor in the department of medical oncology at the University of Paris, said in a prepared statement.

These findings "suggest that a drug such as axitinib has promise as a second-line treatment in cytokine-refractory metastatic renal-cell carcinoma and might have potential as first-line treatment or in combination with other agents," Dr. W. Marston Linehan of the U.S. National Cancer Institute, wrote in an accompanying comment.

More information
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. PCR emerging as a promising technique for Diagnosing Urinary Tuberculosis
2. Experimental treatment for Ebola Virus Shows promising results in mice
3. Promising Treatment for Diabetes
4. A promising treatment for wart removal
5. Hepatitis shots is promising
6. Life after Bypass not so Promising for Women.
7. Promising cure for West Nile Virus
8. Deadly Diarrhoea Vaccine – Trail Results Promising
9. Novartis MS Drug Shows Promising Results
10. Sunitinib a Promising Agent for Treatment of Renal Cell Cancer
11. Research Ethics Requirements Compromising Quality of Health Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... In a April 25, 2015, report published ... the Missouri State Highway Patrol (MSHP) announced that Indiana led ... for the second year in a row. , The ... 1,469 incidents in 2014 alone, around 15% of the national ... the US Population calls Indiana home, according to the report. ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 MAP Health ... and revenue cycle management for addiction treatment facilities, announced ... Vice President of Business Development. Mr. Mooney, who has ... treatment field, will be responsible for developing new strategic ... of MAP’s core products and new initiatives. , Prior ...
(Date:5/5/2015)... ProTexting, LLC – a premier SMS ... Engagement Campaigns and other Mobile solutions, introduces e-mail integration ... leverage the power of Mobile Marketing to expand their ... addresses into the Constant Contact Platform. , ProTexting CEO, ... trend of multi-channel marketing would become more prominent in ...
(Date:5/5/2015)... Bahama (PRWEB) May 05, 2015 Okyanos, ... Orthopedic Lifestyle Report today. The study was conducted to ... such as osteoarthritis and sports-related injuries have ... and stiffness was the most prevalent symptom reported at ... such as walking, standing and bending over. Over half ...
(Date:5/5/2015)... Charleston, SC (PRWEB) May 05, 2015 On ... an episode with Charleston musician Irene Rose about alternatives for ... asked Rose, “How did you get the idea for starting ... Rose replies, “I run an entertainment company called Once Upon ... teach them moral lessons through songs and even scripture. We ...
Breaking Medicine News(10 mins):Health News:A Forever Recovery Releases New Information on the Epidemic Rise Of Methamphetamine Abuse in Midwest America 2Health News:Jimmy Mooney, an Addiction Treatment Veteran, Named Vice President of Business Development at MAP Health Management, LLC 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 3Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 2Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 3Health News:My Positive Perspective Hosts Episode Informing People of a True Princess Summer Camp With Irene Rose 2
... that two recently discovered genes are critically important for ... called E2F7 and E2F8, are the least understood members ... role in animal development. Members of this family are ... and colon., This animal study showed that complete loss ...
... Feb. 4 The Bush administration,s,proposed fiscal year ... Americans,at risk by failing to adequately invest in ... Health Association (APHA) said,today., "While balancing the ... drastically cut funding to crucial health agencies is,short-sighted ...
... Nation, BOUND BROOK, N.J., Feb. 4 ... consider, among other,issues, a Presidential candidate,s position on ... to a universal healthcare,plan has been in effect ... than other U.S. states for health insurance on ...
... dementia, vision loss most in peril, group says ... at high risk for accidental falls and should be regularly ... and deaths in the United States, a new guideline says. ... in 1.8 million emergency room visits and more than 16,000 ...
... The Presidents proposed budget for fiscal year 2009, if ... by extension, our national effort to respond to the ... The Administrations budget flat-funds critical federal support for research ... programs at the Centers for Disease Control and Prevention ...
... High Performance DR ... ... (TSX: IDL), the global leader in high-quality, low-cost digital,radiography systems, today ... Beach in Florida for four of its X-Series,digital radiography systems. IDC ...
Cached Medicine News:Health News:2 genes found to play crucial role in cell survival 2Health News:Public Health Woefully Underfunded in Administration's Proposed Budget 2Health News:Public Health Woefully Underfunded in Administration's Proposed Budget 3Health News:NJ Voters Take Heed: Be Wary of Presidential Candidates Touting Universal Healthcare 2Health News:NJ Voters Take Heed: Be Wary of Presidential Candidates Touting Universal Healthcare 3Health News:New Guideline Urges Screening for Fall Risk 2Health News:2009 Bush budget a disaster for HIV/AIDS 2Health News:Orthopaedic Clinic of Daytona Beach Chooses IDC for Transition to Digital X-ray 2
(Date:5/5/2015)... JERUSALEM , May 5, 2015 ... ) ( http://www.oramed.com ), a clinical-stage pharmaceutical company ... systems, announced today that the company will present ... Oppenheimer 16th Annual Israeli Conference , ,Date: ... ,Presenter:       Nadav Kidron , Chief Executive Officer ...
(Date:5/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4jkc94/clinical ... "Clinical Laboratory,Molecular Diagnostics and Genomic Testing Services Market ... Pacific Version" report to their offering. ... Clinical laboratory testing is positioned to directly benefit ... range of dynamic trends are pushing market growth ...
(Date:5/5/2015)... May 5, 2015  Boehringer Ingelheim Pharmaceuticals, Inc. ... respiratory portfolio will be presented at the 2015 ... May 15-20 in Denver , ... pulmonary disease (COPD) and asthma, and on approved ... Of the 29 accepted abstracts, 19 are on ...
Breaking Medicine Technology:Oramed to Present at Upcoming Conferences 2Oramed to Present at Upcoming Conferences 3Asia Pacific Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Report 2015-2019 2Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 8Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 9Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 10Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 11Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 12Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 13Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 14
... Zogenix, Inc. (NASDAQ: ZGNX ), a ... of central nervous system disorders and pain, announced today ... (NDA) to the U.S. Food and Drug Administration (FDA) ... product candidate for the treatment of chronic pain.     ...
... knows all too well the effects of a busy and ... disease (ARD). But while he,s used to firing up the ... turn down the heat on his heartburn associated with ARD. ... heartburn symptoms of ARD, including through lifestyle modifications, ...
Cached Medicine Technology:Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 2Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 3Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 4Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 5Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain 6Chef Spike Mendelsohn Dishes on How to Turn Down the Heat on Acid Reflux Disease 2Chef Spike Mendelsohn Dishes on How to Turn Down the Heat on Acid Reflux Disease 3Chef Spike Mendelsohn Dishes on How to Turn Down the Heat on Acid Reflux Disease 4Chef Spike Mendelsohn Dishes on How to Turn Down the Heat on Acid Reflux Disease 5
MRI Compatible Slim Line Flowmeter...
0-15 LPM Oxygen Flowmeter with Ohmeda male inlet...
(1/4-15 LPM). 50 psi back inlet, wall mounted, 1/8" NPT female....
Value-Line oxygen flowmeters. ,Options: , For security chain, add suffix S to model number. Example: FMQ107S. , For Canadian Color-Code, add suffix FMQ104C. , For Double Flowmeters with Power Take-Of...
Medicine Products: